Clinical Trial Update: Ketamine Infusion for Treatment-resistant Major Depressive Disorder [NA]

View source ↗

Summary

This is an update on a completed clinical trial (NCT01582945) from Massachusetts General Hospital evaluating ketamine infusion for treatment-resistant major dep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder | NA | Status: COMPLETED | Results posted: 2017-04-20